NAD+ Injection Study

Effects of NAD+ boosting injections on energy levels

Canva Design DAE--pg1p_g

Who can join?

You can join this study if you are: aged 40-65, have a BMI between 25-35, get little to no exercise, and are available to visit our Huntsville AL location on 3 consecutive days. 

Canva Design DAE--pg1p_g

What's involved?

Visit our site on 3 consecutive days for a free NAD+ boosting injection. Each visit is 90 minutes; you will begin with the injection and have a blood draw 90 minutes later. You'll return on day 10 for a final blood draw. 

 

 

Canva Design DAE--pg1p_g

Will I be paid?

Yes! Our team compensates for your time for participating in the study. In addition to receiving all injections at no cost (value of up to $750), you will receive up to $350 for completing the study.

 

What are the steps?

Getting Started

To join the study, complete the form below. Our research team will send you an email with a survey for our team to learn more about your health status.

If our team decides this study is a good fit, you will receive an invitation to schedule your start date. Our team will be available to make sure all your questions are answered. 

 

One

During the Study

While you are in the study, you will come to our site to receive 3 free NAD+ injections over 3 consecutive days. At each of these appointments, you will receive the injection, then complete 2 dried blood spot cards (finger prick), then at the 90 minute mark you will receive a blood draw. The next week, you'll return for a blood draw (roughly 10-15min appointment). 

Two

Payment & Support

Our team is available to you 24/7 during the study. You can reach out at any time with questions. 

Payment is sent via Tango Card. in e-gift cards that can be used at over 100 popular American retailers or for a cash card. You will receive up to $350 for completing this study. Please note: Payments are only sent if all steps in the study have been completed. 

Three

To join this trial, fill out the form below:

Important Info

The purpose of this study is to measure the effects of specialized forms of vitamin B3. The protocol has been evaluated and approved by an independent third-party ethical review board which is accredited by the US Department of Health and Human Services (HHS) Office of Human Research Protections (OHRP). It is conducted in compliance with the Declaration of Helsinki, the Belmont Report, the regulations outlined in 45 CFR 46, and ICH GCP E6 (R2). The protocol is also registered at a World Health Organization (WHO) approved clinical trial registry.